P-178: AT-1 receptor antagonism with candesartan cilexitil improves endothelial function in patients with hypertension and coronary artery disease: A double-blind, randomized, placebo-controlled trial

Endothelial dysfunction (ED) predicts adverse prognosis in patients with coronary artery disease (CAD) and in hypertensives (HTN). Since reversibility of ED has been reported to be associated with more favorable prognosis in HTN, evaluation of the effect of therapy on ED maybe clinically relevant. W...

Full description

Saved in:
Bibliographic Details
Published in:American journal of hypertension 2005-05, Vol.18 (S4), p.71A-71A
Main Authors: Filardi, Pasquale Perrone, Brevetti, Gregorio, Silvestro, Antonio, Corrado, Luigi, Cafiero, Maria, Petretta, Andrea, Caiazzo, Gianluca, Polimeno, Michele, Zarrilli, Annamaria, Camerino, Roberta, Maglione, Antonio, Chiariello, Massimo
Format: Article
Language:English
Subjects:
Endothelial Function
Hypertension
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endothelial dysfunction (ED) predicts adverse prognosis in patients with coronary artery disease (CAD) and in hypertensives (HTN). Since reversibility of ED has been reported to be associated with more favorable prognosis in HTN, evaluation of the effect of therapy on ED maybe clinically relevant. We studied 28 patients (27 men) with controlled HTN and stable asymptomatic CAD while on beta-blocker and nitrate therapy, with evidence of sustained ED assessed by ultrasound measurement of % hyperemic flow-mediated dilation (FMD) of the brachial artery. FMD was evaluated at screening and after a 2 week run-in and only patients with reduced (
ISSN:0895-7061
1879-1905
1941-7225
DOI:10.1016/j.amjhyper.2005.03.196